Kim Julius W, Chang Alan L, Kane J Robert, Young Jacob S, Qiao Jian, Lesniak Maciej S
Prog Neurol Surg. 2018;32:112-123. doi: 10.1159/000469685. Epub 2018 Jul 10.
Despite many recent advances in the management of gliomas, such as aggressive surgical resection, chemoradiotherapy, antiangiogenic therapy, and molecular targeted therapy, the survival of patients with high-grade neoplasms remains dismal. Gene therapy and oncolytic virotherapy have emerged as highly promising strategies for treatment of malignant brain tumors due to recent progress in understanding of the underlying cancer biology as well as improved techniques for genetic modification of potential therapeutics.
尽管近年来在胶质瘤的治疗方面取得了许多进展,如积极的手术切除、放化疗、抗血管生成治疗和分子靶向治疗,但高级别肿瘤患者的生存率仍然很低。由于对潜在癌症生物学的理解取得了新进展以及潜在治疗方法的基因改造技术得到改进,基因治疗和溶瘤病毒疗法已成为治疗恶性脑肿瘤极具前景的策略。